Pablo Rojo Conejo

13PUBLICATIONS
58CO-AUTHORS
Poverty, inclusivity and wellbeingDisease surveillanceMajor global burdens of diseaseAdolescent healthGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 28, 2026
HIV-1 Drug Resistance in Mother-Infant Pairs in Southern Mozambique.

|Jun 03, 2026
Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

|Apr 12, 2026
Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial.

James Wyncoll, Rujirek Kamolrattana, Moherndran Archary

|Feb 24, 2026
SHIELD study: a multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in children and adolescents with HIV who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class antiretroviral (ARV) resistance.

Carlos Grasa, Nicolas Salvadori, Alessandra Nardone

|Jun 06, 2024
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.

Nomonde Bengu, Gabriela Cromhout, Emily Adland

|Nov 19, 2021
Size of HIV-1 reservoir is associated with telomere shortening and immunosenescence in early-treated European children with perinatally acquired HIV-1.

Annalisa Dalzini, Giovanni Ballin, Sara Dominguez-Rodriguez

Pageof 3

Frequent Collaborators

5 joint publications

Paolo Palma

2 joint publications

Gabriela Cromhout

2 joint publications

Andreas Groll

2 joint publications

Nicholas Herbert